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INTRODUCTION
Cord blood (CB) has been successfully used as an important
source of stem cell transplantation since 1988 (1-5). Although
the limited cell dose of CB is a major obstacle for engraftment
in the adult patients, CB can now be considered as an estab-
lished stem cell source for transplantation in the pediatric set-
ting. However, the delay for the engraftment procedure is still
an important clinical problem for children, and the expansion
of CB stem cells is of crucial importance in producing large
numbers of hematopoietic progenitor cells and facilitating
engraftment. The ex vivo expanded CB cells have been suc-
cessfully engrafted into myeloablated animals, as well as adult
human (6-9).
In most studies, the CD34+ cell selection was done before
initiating cell culture (10), but the CD34+ cell selection itself
is associated with a substantial loss of progenitor cells. Another
practical issue is that because most CB units are stored in a
cryopreserved state, the cryopreserved CD34+ cell selection
is associated with increased cell losses as compared to unfrozen
material (11, 12). Several studies have demonstrated that the
hematopoietic potential of cryopreserved CB could be pre-
served, and the purification of CD34+ cells is not essential
for the ex vivo expansion of CB (13, 14). Thus, if the absolute
numbers of progenitor cells are increased after an ex vivo ex-
pansion of cryopreserved and unselected CB, as compared to
fresh and selected CB, it would be much easier, more practi-
cal and cheaper for clinical applications.
Recent studies have also revealed that homing receptors
and chemoattractants have an important association with the
engraftment mechanism after stem cell transplantation (15,
16). If the numbers of progenitor cells as well as homing po-
tential could be increased by the ex vivo expansion of cryo-
preserved and unselected CB, it would be beneficial for trans-
plantation in adult patients, and it would also improve the
engraftment speed. 
We wanted to know whether the larger nucleated cell doses,
as well as increment of stem cells that express homing recep-
tors could be achieved by an ex vivo expansion of cryopre-
served and unselected CB, and we also evaluated the cytokine
combinations that are best for ex vivo expansion of CB.
MATERIALS AND METHODS
Cord blood collection and processing
Twelve CB samples were collected from an umbilical cord
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Stem Cells Expressing Homing Receptors Could be Expanded From 
Cryopreserved and Unselected Cord Blood
We assessed the cytokine combinations that are best for ex vivo expansion of cord
blood (CB) and the increment for cell numbers of nucleated cells, as well as stem
cells expressing homing receptors, by an ex vivo expansion of cryopreserved and
unselected CB. Frozen leukocyte concentrates (LC) from CB were thawed and cul-
tured at a concentration of 1×10
5/mL in media supplemented with a combination
of SCF (20 ng/mL)+TPO (50 ng/mL)+FL (50 ng/mL)±IL-6 (20 ng/mL)±G-CSF
(20 ng/mL). After culturing for 14 days, the expansion folds of cell numbers were as
follows: TNC 22.3±7.8~26.3±4.9, CFU-GM 4.7±5.1~11.7±2.6, CD34+CD38- cell
214.0±251.9~464.1±566.1, CD34+CXCR4+ cell 4384.5±1664.7~7087.2±4669.3,
CD34+VLA4+ cell 1444.3±1264.0~2074.9±1537.0, CD34+VLA5+ cell 86.2±50.9~
113.2±57.1. These results revealed that the number of stem cells expressing hom-
ing receptors could be increased by an ex vivo expansion of cryopreserved and
unselected CB using 3 cytokines (SCF, TPO, FL) only. Further in vivo studies regard-
ing the engraftment after expansion of the nucleated cells, as well as the stem cells
expressing homing receptors will be required.
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vein after full-term vaginal delivery, and they were placed
into transfer bags containing acid citrate dextrose. An informed
consent was obtained from all mothers. Red cells were deplet-
ed with 10% pentastarch (Jeil Pharm, Seoul, Korea) by a den-
sity gradient separation and the resultant leukocyte concen-
trates (LC) were cryopreserved, after the addition of a final
concentration of 10% dimethyl-sulfoxide (Sigma, Sydney,
Austrailia).
Thawing and ex vivo expansion
Frozen LC from CB were thawed in a water bath and wash-
ed by the method of Rubinstein et al. (17). The LC was seed-
ed onto 6-well tissue culture plates at a concentration of 1×
105/mL in media supplemented with a combination of vari-
ous cytokines, and the culturing was carried out without a
medium exchange. After incubation for 2 weeks at 37℃ in
5% CO2 atmosphere, the cells were harvested and assayed.
Recombinant human cytokines
The following recombinant purified human cytokines were
used in these studies: recombinant human (rh) stem cell fac-
tor (SCF; 20 ng/mL, Amgen, Thousand Oaks, CA, U.S.A.), rh
thrombopoietin (TPO; 50 ng/mL, Amgen), rh flt3 ligand (FL;
50 ng/mL, Amgen), rh interleukin 6 (IL-6; 20 ng/mL, Am-
gen), and rh granulocyte colony-stimulating factor (G-CSF;
20 ng/mL, Amgen). The combination of cytokines for each
12 CB samples was as follows: SCF+TPO+FL (group 1),
SCF+TPO+FL+IL-6 (group 2), and SCF+ TPO+FL+IL-6+
G-CSF (group 3).
Clonogenic assays
Nucleated cells before cryopreservation and after 2 weeks
of expansion were seeded onto methylcellulose medium (Stem
Cell Technologies Inc., Vancouver, BC, Canada) at 4×105/
plate in duplicate and incubated for 2 weeks at 37℃in humidi-
fied air and 5% CO2. The granulocyte-macrophage colonies of
more than 50 cells were scored by the use of an inverted micro-
scope.
Nucleated cell count and phenotype analysis 
Total nucleated cell (TNC) counts and the phenotype anal-
ysis were performed before cryopreservation and after 2 weeks
of expansion. TNC counts were performed using an automat-
ed cell analyser, Sysmex K-800 (Sysmex corporation, Kobe,
Japan), and the mononuclear cells were isolated from the CB
for a flow cytometric analysis. Dual-color flow cytometry of
the CD34/CD38 cells, CD 34/CXCR4 cells, CD34/VLA4
cells, and the CD34/VLA5 cells (Becton Dickinson, San Jose,
CA, U.S.A.) was performed using FACSort (Becton Dickin-
son). The cells were stained with the corresponding mono-
clonal antibodies for 45 min. After their incubation, the cells
were washed three times in phosphate-buffered saline, fixed in
1% paraformaldehyde, and analysed by using Lysys II soft-
ware (Becton Dickinson).
Statistics
Results are expressed as the means±standard deviation.
The levels of significance among 3 groups were determined
using an analysis of variance (repeated measure). The SAS
Windows version 6.12 was used for analysis.
RESULTS
The absolute numbers of TNC, CFU-GM, CD34+CD38-
cells, CD34+CXCR4+ cells, CD34+VLA4+ cells and CD34+
VLA5+ cells after ex vivo expansion were compared to the
absolute numbers before cryopreservation. 
Effect of cytokines on the clonogenic potential after expan-
sion of CB 
The expansion folds for cell numbers for TNC were 23.2±
13.8 (group 1), 22.3±7.8 (group 2), 26.3±4.9 (group 3);
CFU-GM were 4.7±5.1 (group 1), 6.0±2.8 (group 2), 11.7
±2.6 (group 3); CD34+CD38- cells were 214.0±251.9
(group 1), 464.1±566.1 (group 2), and 437.4±59.9 (group
3). No significant differences in extent of expansion of TNC,
CFU-GM and CD34+CD38- cells were observed among the
different cytokine combinations (Fig. 1).
Effect of cytokines on the homing potential after expansion
of CB 
The expansion folds for cell numbers were: CD34+CXCR4+
cells 4384.5±1664.7 (group 1), 6149.9±3552.0 (group
2), 7087.2±4669.3 (group3); CD34+VLA4+ cells 1444.3
±1264.0 (group 1), 1832.6±1875.6 (group 2), 2074.9±
1537.0 (group 3); CD34+VLA5+ cells 86.2±50.9 (group
1), 92.8±58.5 (group 2), 113.2±57.1 (group 3). No sig-
nificant differences in extent of expansion of CD34+CXCR4+
cells, CD34+VLA4+ cells and CD34+VLA5+ cells were ob-
served among the different cytokine combinations (Fig. 2).
DISCUSSION
There have been many studies regarding the growth factor
combinations that could stimulate an optimum expansion
of CB progenitor cells in stroma-free liquid culture. Among
the various cytokines, FL, TPO, SCF and IL-6 seems to en-
hance the self-renewal and proliferative potential of primitive
stem cells (18). Since we postulated that the additional pres-Ex Vivo Expansion of Stem Cells Expressing Homing Receptors 637
ence of G-CSF might enhance the differentiation of expand-
ed progenitor cells and increase TNC, which could facilitate
the engraftment speed, we performed our present study with
5 cytokines including FL, TPO, SCF, IL-6 and G-CSF. 
Almost all of the recent ex vivo expansion studies used
freshly prepared or purified CD34+ cells from CB before cryo-
preservation (10, 18). Although Briddell et al. (10) demon-
strated CD34+ cell selection is necessary for the optimal ex-
pansion of clonogenic cells, other studies have revealed that
CD34+ cells and clonogenic cells could be expanded in unse-
lected samples, as in contrast to the selected samples (13, 14).
There may be some concerns regarding the detrimental effects
of cryopreservation on the engraftment potential of expanded
CB, however, DiGiusto et al. (8) and Rice et al. (19) have
demonstrated that cryopreservation does not affect the engraft-
ment potential of the frozen cells. Lazzari et al. (20) have also
recently observed similar clonogenic efficiencies after ex vivo
expansion of both fresh and cryopreserved CD34+ cells.
Since most of CB, that is used for clinical transplantation, is
released from cryopreserved CB banks, it would be reasonable
and practical to establish the protocol for the ex vivo expan-
sion of CB from thawed and unselected state, and that is the
reason why we performed our present study. We examined
the increase of TNC, CFU-GM and CD34+CD38- cells by
ex vivo expansion of cryopreserved and unselected CB. In con-
trast to TNC and CFU-GM, the CD34+CD38- cells, which
are very immature progenitors and preserve their self-renewal
capacity, they dramatically increased. There were no additive
effects of using IL-6 and G-CSF on the expansion potential.
We have demonstrated that the cell doses of immature pro-
genitors could be increased by an ex vivo expansion of cryo-
preserved and unselected CB, and the combination of 3 cyto-
kines (SCF, TPO, FL) is sufficient for this expansion.
There are several adhesion molecules necessarily involved
in the mobilization and homing of CD34+ cells, such as CX
CR4, VLA4 and VLA5. Since VLA4 is important for the early
phase of lodgment of the CD34+ cells after transplantation,
and the CD34+ cells that express high levels of VLA4 have
more proliferative activities (16, 21), then the up-regulation
of these adhesion molecules may be useful for improving en-
graftment in clinical transplantation. Recent studies have
demonstrated that SCF, IL-6, IL-3 and granulocyte-monocyte
colony-stimulating factor (GM-CSF) could induce the up-reg-
ulation of these molecules (22, 23). However, Ramirez et al.
(24) have recently reported that although the expression of
VLA4 and VLA5 was increased after ex vivo expansion, the
adhesion of the progenitor cells to fibronectin was significantly
decreased. A number of studies have also shown that the trans-
plantation of ex vivo expanded progenitors has been associated
with a delayed hematopoietic engraftment, that is, when the
researchers transplanted fresh CD34+ cells or the equivalent
numbers of expanded cells into irradiated NOD/SCID mice
(16, 24, 25).
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Fig. 1. The fold increases for the absolute numbers of total nucle-
ated cells (TNC), colony forming unit-granulocyte/macrophage
(CFU-GM) and CD34+CD38- cells after 14 days of culture in the
presence of various cytokines. SCF, stem cell factor; TPO, throm-
bopoietin; FL, flt3 ligand; IL, interleukin; G-CSF, granulocyte-colony
stimulating factor.
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Fig. 2. The fold increases for the absolute numbers of CD34+CX
CR4+, CD34+VLA4+ and CD34+VLA5+ cells after 14 days of
culture in the presence of various cytokines. SCF, stem cell factor;
TPO, thrombopoietin; FL, flt3 ligand; IL, interleukin; G-CSF, gran-
ulocyte-colony stimulating factor.
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Yet, it would be very important to consider the absolute
cell number, not the relative percentage of CD34+ cells expre-
ssing the marker when evaluating the clonogenic or homing
potential after an ex vivo expansion. So, we evaluated the hom-
ing potential of expanded CB by comparing the absolute num-
ber of CD34+CXCR4+, CD34+VLA4+, CD34+VLA5+ cells
after an ex vivo expansion and before cryopreservation. We
have demonstrated a dramatic increment of the absolute cell
numbers, and particularly for CD34+CXCR4+ and CD 34+
VLA4+ cells, after an ex vivo expansion of the cryopreserved
and unselected CB, and we also found that the combination
of 3 cytokines (SCF, TPO, FL) is sufficient for a large increase
of the stem cells expressing homing receptors.
Based on these data, we conclude that an ex vivo expansion
of cryopreserved and unselected CB using the combinations
of 3 cytokines (SCF, TPO, FL) could be sufficient for trans-
plantation in adults. The number of stem cells expressing
homing receptors could also be increased by an ex vivo expan-
sion, and further in vivo studies regarding the engraftment
potential after up-regulation of the homing receptors, as well
as expansion of primitive stem cells will be required in the
future.
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